Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
66,342,236
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
21,873,216
-
Shares change
-
+21,873,216
-
Total reported value, excl. options
-
$334,224,000
-
Value change
-
+$334,224,000
-
Number of buys
-
45
-
Price
-
$15.28
Significant Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q1 2021
45 filings reported holding BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share as of Q1 2021.
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,873,216 shares
of 66,342,236 outstanding shares and own 32.97% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (12,096,702 shares), MILLENNIUM MANAGEMENT LLC (2,161,024 shares), Redmile Group, LLC (1,500,000 shares), Avidity Partners Management LP (1,254,333 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (957,000 shares), PURA VIDA INVESTMENTS, LLC (877,062 shares), Tamarack Advisers, LP (675,000 shares), BlackRock Inc. (391,826 shares), Alyeska Investment Group, L.P. (279,497 shares), and CAAS CAPITAL MANAGEMENT LP (250,000 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.